Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptor class B member 1 (SCARB1), also known as SR-BI, is a cell surface glycoprotein that serves as a high-affinity receptor for high-density lipoprotein (HDL) and facilitates the selective uptake of cholesteryl esters and lipophilic micronutrients, including carotenoids such as beta-carotene, lutein, and zeaxanthin (Source 1.2.1, 1.5.3). In cancer, SCARB1 is frequently overexpressed on the membranes of various tumor cells, including those of the prostate, breast, and lung, where it supports high metabolic demands by providing lipids for membrane synthesis and antioxidants to mitigate oxidative stress (Source 1.2.2, 1.2.3). This upregulation is often associated with increased tumor aggressiveness, metastasis, and poor clinical outcomes, making it a significant therapeutic target (Source 1.2.2, 1.2.5). Beyond its role in lipid homeostasis, SCARB1 acts as a co-receptor for viruses like Hepatitis C and SARS-CoV-2 (Source 1.2.5). Therapeutic strategies targeting SCARB1 include small-molecule inhibitors like ITX-5061 to block its transport functions and the development of SCARB1-targeted nanoparticles, such as lycosomes, for the selective delivery of chemotherapeutic agents to tumor cells (Source 1.5.2, 1.5.5). Current research also explores its role in regulating signaling pathways like PI3K/AKT and Src, which further drive cancer cell proliferation and survival (Source 1.1.4, 1.2.2).
Selective uptake of carotenoids and cholesteryl esters from high-density lipoproteins (HDL) into the cell membrane without the internalization of the HDL particle itself.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class B member 1 (SCARB1) (SCARB1).